Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Lonza Group    LONN   CH0013841017

LONZA GROUP

(LONN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Lonza : Defense Logistics Agency Energy Aerospace Energy awarded $8m contract for high purity hydrazine

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/18/2019 | 05:01am EDT

Arch Chemicals Inc., Alpharetta, Georgia, has been awarded a maximum $8,076,300 fixed-price, indefinite-delivery/indefinite-quantity requirements contract for high purity hydrazine. This was a sole-source acquisition using justification 10 U.S. Code 2304 (c)(1) as stated in the Federal Acquisition Regulation 6.302-1. This is a one-year contract with no option periods. Locations of performance are California, Florida, and Georgia, with a May 16, 2020, performance completion date. Using customers are Air Force and federal civilian agencies. Type of appropriation is fiscal 2019 through 2020 defense working capital funds. The contracting agency is the Defense Logistics Agency Energy Aerospace Energy, Joint Base San Antonio, Texas (SPE601-19-D-1526).

(c) 2019, The Daily Star. All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LONZA GROUP
09/10LONZA : Announces Refinancing Extension and Increase of Its Term and Revolving B..
AQ
09/10LONZA : Citryll and Lonza Enter Into Partnership to Manufacture NETosis Inhibiti..
AQ
09/03CELLTRION : and Lonza Sign Contract to Manufacture Remsima Drug Substance
AQ
09/03Novartis, Lonza deepen biosimilars push with MS, arthritis drug deals
RE
08/15LONZA : Highlights Cutting-Edge Clean-Label Solutions to Welcome a Healthy Futur..
AQ
08/08LONZA : Welcomes Healthy Future for Brazilian Dietary Supplements Market at Fi S..
AQ
08/01Blue-blooded crabs at heart of pharma dispute on drug testing
RE
07/24Lonza on Track to Deliver Full-Year 2019 Results, Driven by Pharma Biotech Bu..
TE
07/24Lonza Expands Bioconjugation Facility and Announces Approval of Third Commerc..
TE
07/11LONZA : Showcases Innovative Solutions to Make More Possible at the 14th Interna..
AQ
More news
Financials (CHF)
Sales 2019 5 906 M
EBIT 2019 1 205 M
Net income 2019 732 M
Debt 2019 3 247 M
Yield 2019 0,83%
P/E ratio 2019 35,0x
P/E ratio 2020 29,3x
EV / Sales2019 4,90x
EV / Sales2020 4,53x
Capitalization 25 674 M
Chart LONZA GROUP
Duration : Period :
Lonza Group Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LONZA GROUP
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 372,92  CHF
Last Close Price 345,80  CHF
Spread / Highest target 33,6%
Spread / Average Target 7,84%
Spread / Lowest Target -20,5%
EPS Revisions
Managers
NameTitle
Richard Ridinger Chief Executive Officer
Albert M. Baehny Chairman
Rodolfo Savitzky Chief Financial Officer
Patrick Aebischer Vice Chairman
Margot A. Scheltema Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
LONZA GROUP35.77%25 846
IQVIA HOLDINGS INC33.94%30 481
CELLTRION, INC.--.--%18 845
INCYTE CORPORATION27.71%17 466
EXACT SCIENCES CORPORATION64.77%13 463
SEATTLE GENETICS, INC.30.62%12 577